Prescient Mng Corp (PSNTF) 0.2690 $PSNTF Aurora Cannabis

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prescient Mng Corp (PSNTF) 0.2690 $PSNTF

Aurora Cannabis Signs Deal to Construct a New Cannabis Production and Processing Facility in Washington State
Marketwired - Tue Apr 21, 6:31AM CDT
Aurora Cannabis Inc. (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTC: PSNTF) ("Aurora" or the "Company" through its wholly-owned subsidiary, Australis Capital Inc. ("ACI", is pleased to announce that it has entered into a Partnership Agreement dated April 7, 2015, with AJR Builders Group, LLC ("AJR" of Bellingham, Washington, to form a limited liability partnership named, Australis Holdings, LLP ("Australis" to construct a new marijuana production and processing facility in the State of Washington.

Aurora Establishes New Subsidiary
Marketwired - Wed Mar 25, 12:46PM CDT
Aurora Cannabis Inc. (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTC: PSNTF) ("Aurora" or the "Company" is pleased to announce the establishment of its new subsidiary, Australis Capital Inc. ("Australis", a company focused on opportunities in the United States with respect to production, processing, extracting of derivatives and sale of both medicinal and recreational cannabis.

Aurora Signs Consulting Agreement with Electrum Partners, LLC
Marketwired - Wed Mar 18, 8:31AM CDT
Aurora Cannabis Inc. (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTC: PSNTF) ("Aurora" or the "Company" is pleased to announce that it has entered into a consulting agreement (the "Agreement" with Electrum Partners, LLC ("Electrum", an advisory and consulting firm in Las Vegas, Nevada, specializing in the nascent medical marijuana industry in the United States.

Dr. Jason Dyck Joins Aurora's Board of Directors
Marketwired - Tue Mar 10, 8:31AM CDT
Aurora Cannabis Inc. (CSE: ACB) (FRANKFURT: 21P) (WKN: A1C4WM) (OTC: PSNTF) ("Aurora" or the "Company" is pleased to announce the appointment of Dr. Jason Dyck, PhD, to its Board of Directors.

Glenmark Appoints Massey and Schneider to Board
ACCESSWIRE - Wed Feb 11, 3:19PM CST
Vancouver, BC / ACCESSWIRE / February 11, 2015 / Glenmark Capital Corp. (TSX.V: GLM, US OTC: GLRKF and 17G.F) ("Glenmark" or the "Company" is pleased to announce the appointment of Mr. Clive H. Massey as President and Chief Executive Officer of the Company. Mr. Massey has over 25 years of public and private company experience in marketing, finance and public relations in the mining, manufacturing, financial services and technology sectors.

CSE: 2014-1209 - Fundamental Change - Prescient Mining Corp/Aurora Cannabis Inc.
Marketwired - Fri Dec 12, 1:50PM CST
Pursuant to a fundamental change review, the common shares of Aurora Cannabis Inc. have been approved for listing.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading